Journal of Biosciences and Medicines, Год журнала: 2024, Номер 12(12), С. 249 - 260
Опубликована: Янв. 1, 2024
Язык: Английский
Journal of Biosciences and Medicines, Год журнала: 2024, Номер 12(12), С. 249 - 260
Опубликована: Янв. 1, 2024
Язык: Английский
Research Square (Research Square), Год журнала: 2025, Номер unknown
Опубликована: Янв. 2, 2025
Язык: Английский
Процитировано
0Frontiers in Oncology, Год журнала: 2025, Номер 15
Опубликована: Фев. 5, 2025
Background Colorectal cancer (CRC) is the second leading cause of deaths globally, which poses a heavy burden on our healthcare and economy. In recent years, increasing researches suggest that tumor microenvironment (TME) influences onset, progression, metastasis, treatment. This has become popular direction for researching attacking cancer. However, to date, there no bibliometric analysis colorectal from 2014 2024. study aims provide comprehensive picture current research status, hotspots, future trends in this field perspective. Methods study, publications about 2024 were searched based Web Science Core Collection database. Then we analyzed visualized data using CiteSpace, VOSviewer, bibliometrix package, Microsoft Excel 2019. Results A total 748 included number entered period rapid growth after China United States are major collaboration centers field. Elkord, Eyad most prolific author, Frontiers Immunology journal published papers TME CRC. addition, keyword cluster showed immune checkpoint inhibitors, cancer-associated fibroblasts, macrophage polarization, intestinal microbiota, liver drug resistance, scRNA-seq, etc. may be hotspots Conclusions developmental stage, strengthening international cooperation can help drive forward. The main components signaling TME, CRC immunotherapy, new techniques hot directions domain. Our findings will scholars with an up-to-date perspective state research,
Язык: Английский
Процитировано
0Journal of Immunology Research, Год журнала: 2025, Номер 2025(1)
Опубликована: Янв. 1, 2025
Colorectal cancer (CRC) stands as one of the tumors with globally high incidence and mortality rates. In recent years, researchers have extensively explored role tumor immune microenvironment (TME) in CRC, highlighting crucial influence cell populations driving progression shaping therapeutic outcomes. The TME encompasses an array cellular noncellular constituents, spanning cells, myeloid tumor-associated fibroblasts, among others. However, composition within is highly dynamic, evolving throughout different stages progression. These shifts subpopulation proportions lead to a gradual transition response, shifting from early antitumor growth late-stage environment that supports survival. Therefore, it further investigate understand complex interactions various TME. this review, we explore key components varying origins, subpopulations shared elements CRC TME, examining their interconnections critical considerations for developing personalized precise immunotherapy strategies.
Язык: Английский
Процитировано
0Journal of Translational Medicine, Год журнала: 2024, Номер 22(1)
Опубликована: Окт. 1, 2024
Язык: Английский
Процитировано
0Journal of Biosciences and Medicines, Год журнала: 2024, Номер 12(12), С. 249 - 260
Опубликована: Янв. 1, 2024
Язык: Английский
Процитировано
0